AcelRx Pharmaceuticals Inc (ACRX):企業の財務・戦略的SWOT分析

◆英語タイトル:AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH26475FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AcelRx Pharmaceuticals Inc (ACRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo in Europe), is a single sufentanil sublingual tablet for treating of moderate-to-severe acute pain. Its pipeline also includes Zalviso (for US market), a drug and device combination product for management of moderate to severe acute pain in adults. AcelRx developed a proprietary, non-invasive, sublingual formulation technology to deliver its highly lipophilic drugs. The company commercializes its EC approved Zalviso under license agreement with Grunenthal in Europe and Australia. AcelRx is headquartered in Redwood City, California, the US.

AcelRx Pharmaceuticals Inc Key Recent Developments

Nov 05,2020: AcelRx Pharmaceuticals reports third quarter 2020 financial results
Aug 10,2020: AcelRx Pharmaceuticals reports second quarter 2020 financial results
May 11,2020: AcelRx Pharmaceuticals reports first quarter 2020 financial results
Mar 17,2020: Tetraphase Pharmaceuticals to merge with AcelRx
Mar 16,2020: AcelRx Pharmaceuticals reports fourth quarter and full year 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AcelRx Pharmaceuticals Inc – Key Facts
AcelRx Pharmaceuticals Inc – Key Employees
AcelRx Pharmaceuticals Inc – Key Employee Biographies
AcelRx Pharmaceuticals Inc – Major Products and Services
AcelRx Pharmaceuticals Inc – History
AcelRx Pharmaceuticals Inc – Company Statement
AcelRx Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AcelRx Pharmaceuticals Inc – Business Description
Other Break-up: Contract and Other Collaboration
Overview
Performance
Other Break-up: Product Sales
Overview
Performance
AcelRx Pharmaceuticals Inc – Corporate Strategy
AcelRx Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
AcelRx Pharmaceuticals Inc – Strengths
AcelRx Pharmaceuticals Inc – Weaknesses
AcelRx Pharmaceuticals Inc – Opportunities
AcelRx Pharmaceuticals Inc – Threats
AcelRx Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AcelRx Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 05, 2020: AcelRx Pharmaceuticals reports third quarter 2020 financial results
Aug 10, 2020: AcelRx Pharmaceuticals reports second quarter 2020 financial results
May 11, 2020: AcelRx Pharmaceuticals reports first quarter 2020 financial results
Mar 17, 2020: Tetraphase Pharmaceuticals to merge with AcelRx
Mar 16, 2020: AcelRx Pharmaceuticals reports fourth quarter and full year 2019 financial results
Jan 13, 2020: AcelRx announces year-end 2019 metrics and provides corporate updates
Nov 06, 2019: AcelRx Pharmaceuticals reports third quarter 2019 financial results
Nov 05, 2019: AcelRx Pharmaceuticals to present at Credit Suisse 28th Annual Healthcare Conference
Oct 16, 2019: Dr. TJ Gan to present at the 2019 Annual Meeting of the American Society of Anesthesiologists
Aug 05, 2019: AcelRx Pharmaceuticals reports second quarter 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
AcelRx Pharmaceuticals Inc, Key Facts
AcelRx Pharmaceuticals Inc, Key Employees
AcelRx Pharmaceuticals Inc, Key Employee Biographies
AcelRx Pharmaceuticals Inc, Major Products and Services
AcelRx Pharmaceuticals Inc, History
AcelRx Pharmaceuticals Inc, Subsidiaries
AcelRx Pharmaceuticals Inc, Key Competitors
AcelRx Pharmaceuticals Inc, Ratios based on current share price
AcelRx Pharmaceuticals Inc, Annual Ratios
AcelRx Pharmaceuticals Inc, Annual Ratios (Cont...1)
AcelRx Pharmaceuticals Inc, Interim Ratios
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AcelRx Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[AcelRx Pharmaceuticals Inc (ACRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caixa Economica Federal
    Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Congenica Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers research and experimental development on biotechnology. The company’s technology SAPIENTIA, is used to personalize patient care through accurate diagnoses, support clinical trials, and drug development. It offers services such …
  • ALLETE Inc (ALE):企業の財務・戦略的SWOT分析
    ALLETE Inc (ALE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • American International Group Inc:企業の戦略・SWOT・財務情報
    American International Group Inc - Strategy, SWOT and Corporate Finance Report Summary American International Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Global Tungsten & Powders Corp.:企業の戦略・SWOT・財務情報
    Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report Summary Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • The Whiting-Turner Contracting Co:企業の戦略・SWOT・財務分析
    The Whiting-Turner Contracting Co - Strategy, SWOT and Corporate Finance Report Summary The Whiting-Turner Contracting Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Asarina Pharma AB-製薬・医療分野:企業M&A・提携分析
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB is a drug development company that concentrates on the discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cycl …
  • Enel SpA (ENEL):電力:M&Aディール及び事業提携情報
    Summary Enel SpA (Enel) is an integrated electricity and gas company that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on di …
  • Kuala Lumpur Kepong Berhad (KLK):企業の財務・戦略的SWOT分析
    Kuala Lumpur Kepong Berhad (KLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hargreaves Lansdown PLC:企業の戦略・SWOT・財務情報
    Hargreaves Lansdown PLC - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Lansdown PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cloud Live Technology Group Co. Ltd.:企業の戦略・SWOT・財務分析
    Cloud Live Technology Group Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cloud Live Technology Group Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Novo Nordisk AS (NOVO B):企業の財務・戦略的SWOT分析
    Novo Nordisk AS (NOVO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • NCsoft Corp (036570):企業の財務・戦略的SWOT分析
    NCsoft Corp (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Compass Group PLC:戦略・SWOT・企業財務分析
    Compass Group PLC - Strategy, SWOT and Corporate Finance Report Summary Compass Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • High Peak Royalties Limited (HPR)-石油・ガス分野:企業M&A・提携分析
    Summary High Peak Royalties Limited (High Peak) is a utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The company has r …
  • St. Jude Medical LLC-医療機器分野:企業M&A・提携分析
    Summary St. Jude Medical LLC (SJM), a part of Abbott Laboratories, is a medical device company. It develops and manufactures devices for the cardiac rhythm management, cardiovascular, cardiac surgery and atrial fibrillation therapy areas, and implantable neurostimulation devices for the management o …
  • Diehl Stiftung & Co. KG:企業の戦略・SWOT・財務情報
    Diehl Stiftung & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Diehl Stiftung & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Junex Inc (JNX):石油・ガス:M&Aディール及び事業提携情報
    Summary Junex Inc (Junex) is an oil and natural gas exploration company. It carries out oil and natural gas exploration in Canada and the US. In Canada, the company has assets in sedimentary basins in the St. Lawrence Lowlands, on the Gaspe Peninsula, and on Anticosti Island. In the US, Junex holds …
  • Vaccitech Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccitech Ltd (Vaccitech) is a clinical stage company that focuses on the development of universal flu vaccines. The company is developing clinical programs for the treatment of influenza, prostate cancer, HBV, Middle East respiratory syndrome (MERS), shingles, human papillomavirus (HPV), an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆